| | 287714-41-4 Basic information More.. |
| Product Name: | Rosuvastatin | | Synonyms: | 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid;ROSUVASTATIN-D3 SODIUM SALT;(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-MethylMethanesulfonaMido)-6-(propan-2-yl)pyriMidin-5-yl]-3,5-dihydroxyhept-6-enoic acid;(3R,5S,E)-7-(4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid;R-2: TERT-BUTYL-(+) 7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLSULFONYLAMINO) PYRIMIDINE-5-YL]-(3R, 5S)-DIOXANE-(E)-6-HEPTENATE;Rosuvastatin;Rosuvastatin Impurity 21;CS-111 | | CAS: | 287714-41-4 | | MF: | C22H28FN3O6S | | MW: | 481.54 | | EINECS: | 689-191-5 | | Mol File: | 287714-41-4.mol |  |
Use
Rosuvastatin is the most recent FDA-approved statin (doses 5–40 mg) for the treatment of dyslipidemia. Rosuvastatin, which has a structure similar to other synthetic statins, has a long halflife (20–24 hours) similar to atorvastatin and hydrophilicity comparable to pravastatin. Consequently, rosuvastatin is minimally metabolized and has no significant cytochrome P450 drug interactions. The efficacy of rosuvastatin is superior to that of other statins. Compared to atorvastatin, rosuvastatin provides approximately an 8% additional lowering of LDL-C on an equivalent dose level. This provides modestly more efficacy than a doubling of the dose of atorvastatin. Rosuvastatin also increases HDL-C slightly more than atorvastatin, especially at the highest doses.
- Rosuvastatin
-
- US $0.00 / kg
- 2023-11-27
- CAS:287714-41-4
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 5o0kg
- Rosuvastatin
-
- US $0.00-0.00 / KG
- 2023-11-01
- CAS:287714-41-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 300
- Rosuvastatin
-
- US $0.00 / KG
- 2023-01-31
- CAS:287714-41-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
|
|
287714-41-4
Recommend Suppliers |
|